Share

MENA expected to see 45 tech start-ups with unicorn status

Combined value of fast-growing start-ups could come close to $100 bn
MENA expected to see 45 tech start-ups with unicorn status
Saudi Arabia

The Middle East and North Africa (MENA) region has the potential to create 45 tech start-ups worth close to $100 billion (unicorn status) by 2030, according to a new report released by Saudi Technology Ventures (STV). 

The prediction by STV is based on technology, consumer adoption, broad macroeconomic and regulatory reforms, and a growing talent pool – all of which cater to the MENA’s technology-driven population.

“We believe the region can output 45 unicorns by 2030 and can create digital giants that can list on public markets, remain independent, and keep their focus on delivering innovative solutions tailored to local needs,” STV said.

The study produced by the venture capital fund cited the region’s youthful population, 55 percent under 30, growing at 1.6 percent per year, as well as its high average daily social media consumption of 3.5 hours.

The region also has the highest percentage of “unbanked” consumers, or those without bank accounts, at 45 percent, leading to large potential for fintech businesses, the report said.

Similarly, Saudi was titled the “gravitational center” of the region, in terms of scaling technology companies.

The two main drivers of Saudi’s status as a hub for tech start-ups are its GDP, which accounts for one-third of the region’s GDP, and the size and depth of its stock exchange, STV said. New development programs and company laws designed to encourage innovation and remove barriers also play a part. 

Moreover, Magnitt’s latest report showed that the venture capital funding in Saudi surged more than threefold to $584 million in the first half of 2022, surpassing the total for the whole of 2021.

Disclaimer: The content of this article is intended for informational purposes only.It does not constitute advice on tax and legal matters; neither are they financial or investment recommendations. Refer to our full disclaimer policy here.